Health and Fitness Health and Fitness
Tue, June 21, 2011
Mon, June 20, 2011
Sun, June 19, 2011
Fri, June 17, 2011
Thu, June 16, 2011
Wed, June 15, 2011
Tue, June 14, 2011
[ Tue, Jun 14th 2011 ] - Market Wire
Bond Labs Reports May Results
Mon, June 13, 2011
Fri, June 10, 2011
Thu, June 9, 2011
Wed, June 8, 2011
Tue, June 7, 2011
Mon, June 6, 2011
Sat, June 4, 2011
Fri, June 3, 2011
Thu, June 2, 2011
Wed, June 1, 2011
Tue, May 31, 2011
Mon, May 30, 2011
Fri, May 27, 2011
Thu, May 26, 2011
Wed, May 25, 2011
Tue, May 24, 2011
Mon, May 23, 2011
Sun, May 22, 2011
Fri, May 20, 2011

Cumberland Pharmaceuticals to Present at the 2011 Wells Fargo Securities Healthcare Conference in Boston


//health-fitness.news-articles.net/content/2011/ .. -securities-healthcare-conference-in-boston.html
Published in Health and Fitness on Tuesday, June 7th 2011 at 18:00 GMT by Market Wire   Print publication without navigation


Cumberland Pharmaceuticals to Present at the 2011 Wells Fargo Securities Healthcare Conference... -- NASHVILLE, Tenn., June 7, 2011 /PRNewswire/ --

Cumberland Pharmaceuticals to Present at the 2011 Wells Fargo Securities Healthcare Conference in Boston

[ ]

NASHVILLE, Tenn., June 7, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the Wells Fargo Securities Healthcare Conference in Boston at 2:30 p.m. Eastern Time on Wednesday, June 22, 2011.

The presentation will be simultaneously webcast and can be accessed by visiting the Investor Relations section on Cumberland Pharmaceuticals' website at [ www.cumberlandpharma.com ].

Shortly following the live webcast a replay will also be available on the Company website.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc. is a Tennessee-based specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland markets Acetadote® for the treatment of acetaminophen poisoning, Caldolor®, the first injectable treatment for pain and fever approved in the United States, and Kristalose®, a prescription laxative. Cumberland is dedicated to providing innovative products that improve quality of care for patients.  

For more information on Cumberland Pharmaceuticals, please visit the Company website at [ www.cumberlandpharma.com ].

SOURCE Cumberland Pharmaceuticals Inc.

[ Back to top ]

RELATED LINKS
[ http://www.cumberlandpharma.com ]


Publication Contributing Sources